Publication in „Nature“: Researchers led by DZNE analyze medical data with a novel artificial intelligence technology. Collaboration with Hewlett Packard Enterprise.
A research group involving the DZNE has successfully developed a new method of gene regulation that permanently reduces the protein "tau" in the adult brain. This could become the basis for new therapies against Alzheimer's and other neurodegenerative diseases.
The DZNE and Eisai Co., Ltd. announce that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders.
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.